Cision PR Newswire

OncoC4 Announces NMPA Acceptance of Two IND Applications for Cesalatamig Combination Studies with ADCs and Pan-RAS Inhibitors

— New Studies Expand Cesalatamig into Biomarker-driven Precision Immuno-oncology Strategies — Cesalatamig is Also Being Evaluated in Ongoing Phase 2 Studies in the...

Julia Gillard joins Hakluyt’s International Advisory Board

LONDON, Oct. 19, 2026 /PRNewswire/ -- Hakluyt, the global strategic advisory firm for businesses...

2026 Canton Fair Design Award Winners Showcase China’s Innovation Strength

GUANGZHOU, China, Oct. 19, 2026 /PRNewswire/ -- As the 140th Canton Fair opens, the winners...

OCI GLOBAL CONFIRMS EURO EQUIVALENT DETAILS FOR Q2 2025 EXTRAORDINARY DISTRIBUTION

AMSTERDAM, April 16, 2025 /PRNewswire/ -- OCI Global (Euronext: OCI) ("OCI" or the "Company") today confirms that further to its announcement to pay an...

Frost & Sullivan Recognizes Ontic with the 2025 Global Company of the Year Award for Revolutionizing Security Intelligence

Ontic's unified platform empowers corporate security teams to manage threats, mitigate risks, and make businesses stronger.     SAN ANTONIO, April 16, 2025 /PRNewswire/ -- Frost...

Porton Advanced’s End-to-End CDMO Solutions Accelerates IND Approval of Tasly’s Innovative Dual-Targeting CAR-T Therapy

SUZHOU, China, April 16, 2025 /PRNewswire/ -- April 12, 2025, Porton Advanced proudly announces its CDMO support for TASLY PHARMACEUTICAL CO., LTD's Innovative Dual-Targeting...